Investor Centre

Pharmaxis Ltd refers to its announcement on 26 February 2016 relating to the establishment of an unmarketable parcel share sale facility.

A total of 1,103 shareholders with an aggregate of 844,375 shares participated in the sale facility.  These shares were sold on-market and the proceeds will be distributed on or about 6 May 2016 to the participants.

As a result of the share sale facility, Pharmaxis' shareholder base reduces to approximately 5,150 holders.